NPI: 1831166826 · BEAUMONT, MS 39423 · Federally Qualified Health Center (FQHC) · NPI assigned 03/08/2006
Authorized official ROBINSON, JANICE controls 20+ related entities in our dataset. Read more
| Authorized Official | ROBINSON, JANICE (EXECUTIVE DIRECTOR) |
| Parent Organization | SOUTHEAST MISSISSIPPI RURAL HEALTH INITIATIVE, INC |
| NPI Enumeration Date | 03/08/2006 |
Other providers sharing the same authorized official: ROBINSON, JANICE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,353 | $79K |
| 2019 | 1,728 | $107K |
| 2020 | 1,110 | $79K |
| 2021 | 1,396 | $71K |
| 2022 | 4,053 | $99K |
| 2023 | 3,927 | $91K |
| 2024 | 2,347 | $50K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,977 | 3,483 | $472K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 793 | 711 | $92K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 48 | 48 | $7K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 570 | 496 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 56 | 27 | $166.16 |
| 83655 | 26 | 26 | $148.06 | |
| 36415 | Collection of venous blood by venipuncture | 72 | 68 | $110.70 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 809 | 689 | $30.00 |
| 3074F | 1,435 | 1,225 | $0.00 | |
| 36416 | 124 | 120 | $0.00 | |
| 3008F | 1,775 | 1,491 | $0.00 | |
| 85018 | 100 | 99 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 194 | 170 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 71 | 55 | $0.00 |
| 90686 | 28 | 27 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 26 | 25 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 157 | 115 | $0.00 |
| 92551 | 71 | 71 | $0.00 | |
| 3079F | 32 | 28 | $0.00 | |
| 1160F | 1,802 | 1,534 | $0.00 | |
| 3078F | 1,284 | 1,098 | $0.00 | |
| 1159F | 1,802 | 1,535 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 519 | 446 | $0.00 |
| 81002 | 13 | 12 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15 | 14 | $0.00 |
| 90715 | 12 | 12 | $0.00 | |
| 99173 | 103 | 99 | $0.00 |